These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21595995)

  • 1. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer.
    Wang R; Lu M; Zhang J; Chen S; Luo X; Qin Y; Chen H
    J Exp Clin Cancer Res; 2011 May; 30(1):62. PubMed ID: 21595995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
    Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
    Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer.
    Yang L; Dong Y; Li Y; Wang D; Liu S; Wang D; Gao Q; Ji S; Chen X; Lei Q; Jiang W; Wang L; Zhang B; Yu JJ; Zhang Y
    Int J Cancer; 2019 Aug; 145(4):1099-1110. PubMed ID: 30671927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer.
    Zeni E; Mazzetti L; Miotto D; Lo Cascio N; Maestrelli P; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
    Eur Respir J; 2007 Oct; 30(4):627-32. PubMed ID: 17537769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
    Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
    Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
    Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
    Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC).
    Sui JYAX
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental Growth Factor Mediates Crosstalk Between Lung Cancer Cells and Tumor-Associated Macrophages in Controlling Cancer Vascularization and Growth.
    He C; Zhu K; Bai X; Li Y; Sun D; Lang Y; Ning J; Sun F; Qu C; Xu S
    Cell Physiol Biochem; 2018; 47(6):2534-2543. PubMed ID: 29991059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
    Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM
    Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
    J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer.
    Zhang G; Liu H; Huang J; Chen S; Pan X; Huang H; Wang L
    Oncotarget; 2016 Jun; 7(26):40508-40517. PubMed ID: 27244892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer.
    Sumitomo R; Hirai T; Fujita M; Murakami H; Otake Y; Huang CL
    Lung Cancer; 2019 Oct; 136():136-144. PubMed ID: 31499335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
    Bonde AK; Tischler V; Kumar S; Soltermann A; Schwendener RA
    BMC Cancer; 2012 Jan; 12():35. PubMed ID: 22273460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization.
    Li Z; Feng C; Guo J; Hu X; Xie D
    Funct Integr Genomics; 2020 Jan; 20(1):17-28. PubMed ID: 31267263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.